Last updated on March 2019

Efficacy and Safety of Intravenous Neridronic Acid in CRPS


Brief description of study

The aim of this trial is to investigate the efficacy and safety of intravenous neridronic acid in subjects with Complex Regional Pain Syndrome (CRPS).

The trial consists of an Enrollment Period lasting up to 60 days, Treatment Period A consisting of 4 infusions (neridronic acid or placebo) over 10 days, and a Follow-up Period 1 until Week 26.

At Week 26, participants not meeting the pre-specified criteria to continue into Treatment Period B will continue in Follow-up Period 2 until Week 52. Participants meeting the pre-specified criteria will enter the open-label Treatment Period B with 4 additional infusions (neridronic acid) over 10 days and follow-up visits until Week 52.

Clinical Study Identifier: NCT03530345

Contact Investigators or Research Sites near you

Start Over

US040 - Regeneris Medical

North Attleboro, MA United States
3.88miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.